Kung Winston
SEC CIK 1666963 · EDGAR
BoughtSold
Most active insiders at JANX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Meyer Andrew Hollman | Chief Business Off | — | $736.7K |
| 2 | Campbell David Alan | Pres, CEO, Dir | — | $110.8K |
| 3 | Doyle Janeen Noel | Chief Corp, Bus. Dev. Ofcr | — | $56.9K |
| 4 | Dobek Maria | VP, Accounting | — | $49.0K |
| 5 | McIver Zachariah | Chief Medical Off | — | $37.3K |
| 6 | DiRaimondo Thomas | CSO | — | $34.4K |
| 7 | Winter Charles M. | Chief Technical Off | — | $33.0K |
| 8 | Go William | Chief Medical Off | — | — |
| 9 | Simson Jake | Dir | — | — |
| 10 | Hernday Natasha | Dir | — | — |
| 11 | Kung Winston | Dir | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-12 20:00 | 2026-06-11 | JANX | Janux Therapeutics, Inc. | Kung Winston | Dir | A - Grant | $0.00 | +5,500 | 11.8K | +88% | $0 |
| T | 2026-06-11 16:30 | 2026-06-10 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Kung Winston | Dir | S - Sale | $7.91 | -2,026 | 12.1K | -14% | -$16.0K |
| D | 2026-05-21 17:07 | 2026-05-19 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Kung Winston | Dir | A - Grant | $0.00 | +3,800 | 14.2K | +37% | $0 |
| D | 2025-06-13 | 2025-06-11 | JANX | Janux Therapeutics, Inc. | Kung Winston | Dir | A - Grant | $0.00 | +3,750 | 6,250 | +150% | $0 |
| D | 2025-06-02 | 2025-05-30 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Kung Winston | Dir | A - Grant | $0.00 | +4,800 | 10.4K | +86% | $0 |
| D | 2024-08-20 | 2024-08-16 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Kung Winston | Dir | A - Grant | $0.00 | +5,566 | 5,566 | New | $0 |
| D | 2024-06-28 | 2024-06-26 | JANX | Janux Therapeutics, Inc. | Kung Winston | Dir | A - Grant | $0.00 | +2,500 | 2,500 | New | $0 |
| 2023-01-30 | 2022-11-25 | PMVP | PMV Pharmaceuticals, Inc. | Kung Winston | COO, CFO | G - Gift | $0.00 | -2,560 | 10.6K | -19% | $0 | |
| D | 2022-04-21 | 2022-04-20 | PMVP | PMV Pharmaceuticals, Inc. | Kung Winston | COO, CFO | M - OptEx | $3.22 | +4,000 | 10.6K | +61% | +$12.9K |
| 2022-02-08 | 2021-12-30 | PMVP | PMV Pharmaceuticals, Inc. | Kung Winston | COO, CFO | G - Gift | $0.00 | -2,725 | 6,600 | -29% | $0 | |
| D | 2021-08-20 | 2021-08-19 | PMVP | PMV Pharmaceuticals, Inc. | Kung Winston | COO, CFO | M - OptEx | $3.22 | +5,000 | 6,600 | +312% | +$16.1K |
| D | 2021-08-04 | 2021-08-03 | PMVP | PMV Pharmaceuticals, Inc. | Kung Winston | COO, CFO | M - OptEx | $3.22 | +4,500 | 6,100 | +281% | +$14.5K |
| D | 2021-08-04 | 2021-08-03 | PMVP | PMV Pharmaceuticals, Inc. | Kung Winston | COO, CFO | S - Sale+OE | $33.82 | -4,500 | 1,600 | -74% | -$152.2K |
| D | 2021-07-08 | 2021-07-08 | PMVP | PMV Pharmaceuticals, Inc. | Kung Winston | COO, CFO | M - OptEx | $3.22 | +4,500 | 6,100 | +281% | +$14.5K |
| D | 2021-07-08 | 2021-07-08 | PMVP | PMV Pharmaceuticals, Inc. | Kung Winston | COO, CFO | S - Sale+OE | $33.75 | -4,500 | 1,600 | -74% | -$151.9K |
Purchase Sale Sale after option exercise All abbreviations